You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 137 No. 11, November 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  Review
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (32)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Neoplasms
 •Review
 •Genetics
 •Genetic Disorders
 •Alert me on articles by topic


Genetic Epidemiology of Cutaneous Melanoma

A Global Perspective

Alisa M. Goldstein, PhD; Margaret A. Tucker, MD

Arch Dermatol. 2001;137:1493-1496.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

INTRODUCTION

Cutaneous malignant melanoma (CMM) results from the interaction of genetic, host, and environmental influences. Epidemiologic studies of melanoma have shown that the major environmental risk factor is UV radiation. The exposure-response relationship, however, seems complex, with intermittent sun exposure likely to be more important for risk than total lifetime exposure (for a review, see Armstrong and English1). The host factors most strongly associated with melanoma are melanocytic nevi (moles), both clinically banal and atypical (dysplastic).1-2 Other host factors implicated in melanoma include fair hair color, light eye color, increased freckling, and an inability to tan. Nonmelanoma skin cancer (basal cell or squamous cell carcinoma) also increases the risk for melanoma.1

Approximately 5% to 12% of malignant melanomas develop in individuals who have 1 or more first-degree relatives with CMM.3 Such clustering is denoted familial melanoma. No precise definition exists for the . . . [Full Text of this Article]

MELANOMA PREDISPOSITION GENES

CDKN2A

CDKN2A: FUTURE STUDIES

FUTURE GENETIC EPIDEMIOLOGIC RESEARCH

MUTATION TESTING

CONCLUSIONS

From the Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Md.


RELATED ARTICLE

Archives of Dermatology Reader's Choice: Continuing Medical Education
Arch Dermatol. 2001;137(11):1541.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Relevance of Genetics and Genomics for Prevention and Treatment of Cardiovascular Disease: A Scientific Statement From the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group
Arnett et al.
Circulation 2007;115:2878-2901.
ABSTRACT | FULL TEXT  

Genetic variants of the ADPRT, XRCC1 and APE1 genes and risk of cutaneous melanoma
Li et al.
Carcinogenesis 2006;27:1894-1901.
ABSTRACT | FULL TEXT  

Prospective risk of cancer in CDKN2A germline mutation carriers
Goldstein et al.
J. Med. Genet. 2004;41:421-424.
ABSTRACT | FULL TEXT  

Pancreatic Carcinoma Surveillance in Patients With Familial Melanoma
Parker et al.
Arch Dermatol 2003;139:1019-1025.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.